AA
ALPS Advisors Portfolio holdings
AUM
$17.3B
This Quarter Return
+0.5%
1 Year Return
+13.43%
3 Year Return
+69.62%
5 Year Return
+161.48%
10 Year Return
+94.79%
AUM
$13.5B
AUM Growth
+$13.5B
(-4.3%)
Cap. Flow
-$602M
Cap. Flow
% of AUM
-4.46%
Top 10 Holdings %
Top 10 Hldgs %
48.28%
Holding
914
New
36
Increased
205
Reduced
622
Closed
38
Top Buys
| 1 |
MPLX
MPLX
|
$30.4M |
| 2 |
Energy Transfer Partners
ET
|
$23.5M |
| 3 |
Franklin FTSE Japan ETF
FLJP
|
$11.8M |
| 4 |
Wells Fargo
WFC
|
$9.77M |
| 5 |
Western Digital
WDC
|
$8.83M |
Top Sells
| 1 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
$51.3M |
| 2 |
Enterprise Products Partners
EPD
|
$49.2M |
| 3 |
BPL
Buckeye Partners, L.P.
BPL
|
$46.3M |
| 4 |
Western Midstream Partners
WES
|
$44.8M |
| 5 |
EQM
EQM Midstream Partners, LP
EQM
|
$28.4M |
Sector Composition
| 1 | Energy | 65.41% |
| 2 | Financials | 7.05% |
| 3 | Healthcare | 3.6% |
| 4 | Consumer Discretionary | 3.1% |
| 5 | Technology | 2.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
901
Groupon
GRPN
$990M
| – | – |
-23,948
| Closed | -$85K |
|
902
Green Plains
GPRE
$708M
| – | – |
-31,421
| Closed | -$524K |
|
903
Genworth Financial
GNW
$3.51B
| – | – |
-15,317
| Closed | -$59K |
|
904
Galapagos
GLPG
$2.06B
| – | – |
-87,116
| Closed | -$10.3M |
|
905
Forte Biosciences
FBRX
$138M
| – | – |
-55,440
| Closed | -$603K |
|
906
CRISPR Therapeutics
CRSP
$4.82B
| – | – |
-125,116
| Closed | -$4.47M |
|
907
Catalyst Pharmaceutical
CPRX
$2.42B
| – | – |
-248,154
| Closed | -$1.27M |
|
908
CASI Pharmaceuticals
CASI
$36.1M
| – | – |
-230,154
| Closed | -$661K |
|
909
Braskem
BAK
$1.31B
| – | – |
-22,764
| Closed | -$588K |
|
910
Atara Biotherapeutics
ATRA
$88.7M
| – | – |
-110,257
| Closed | -$4.38M |
|
911
Ascendis Pharma
ASND
$12.1B
| – | – |
-70,468
| Closed | -$8.29M |
|
912
Akebia Therapeutics
AKBA
$827M
| – | – |
-282,329
| Closed | -$2.31M |
|
913
Arbutus Biopharma
ABUS
$753M
| – | – |
-134,053
| Closed | -$480K |
|
914
Abeona Therapeutics
ABEO
$356M
| – | – |
-115,800
| Closed | -$852K |
|